SCHEMBL8309616

SCHEMBL8309616

C/C(=N/OCCOc1ccc(CC2SC(=O)N(C(c3ccccc3)(c3ccccc3)c3ccccc3)C2=O)cc1)c1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.50
PPARA Q07869 1/20 0.36
S1PR1 P21453 2/20 0.36
FFAR1 O14842 6/20 0.35
LMNA P02545 2/20 0.35
BCL2 P10415 1/20 0.34
HTT P42858 1/20 0.34
MAPT P10636 1/20 0.34
CFTR P13569 1/20 0.33
PTBP1 P26599 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309618 1.00 PPARG (0.50) PPARGPPARAS1PR1FFAR1LMNA
SCHEMBL8307062 0.95 PPARG (0.55) PPARGS1PR1FFAR1BCL2HTT
SCHEMBL8307060 0.95 PPARG (0.55) PPARGS1PR1FFAR1BCL2HTT
SCHEMBL8304209 0.93 PPARG (0.49) PPARGPPARAS1PR1FFAR1BCL2
SCHEMBL8304210 0.93 PPARG (0.49) PPARGPPARAS1PR1FFAR1BCL2
SCHEMBL8309781 0.93 PPARG (0.51) PPARGPPARAS1PR1FFAR1LMNA
SCHEMBL8309782 0.93 PPARG (0.51) PPARGPPARAS1PR1FFAR1LMNA
SCHEMBL8444587 0.91 PPARG (0.51) PPARGS1PR1FFAR1BCL2HTT
SCHEMBL8305089 0.90 PPARG (0.51) PPARGS1PR1FFAR1LMNAHTT
SCHEMBL8305087 0.90 PPARG (0.51) PPARGS1PR1FFAR1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed